VBI Vaccines Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2002
Net Income	-82.99	-93.84	-113.3	-69.75	-46.23	-54.81	Upgrade
Depreciation & Amortization	1.98	1.99	2.06	1.84	1.65	1.2	Upgrade
Share-Based Compensation	5.23	6.66	9.7	9.63	5.29	3.94	Upgrade
Other Operating Activities	24.78	23.3	27.85	18.38	-7.76	0.96	Upgrade
Operating Cash Flow	-51	-60.88	-73.7	-39.91	-47.05	-48.71	Upgrade
Capital Expenditures	-0.48	-0.87	-4.34	-2	-1	-3.67	Upgrade
Change in Investments	0	0	0	25.15	-25	0	Upgrade
Investing Cash Flow	-0.48	-0.87	-4.34	23.16	-26	-3.67	Upgrade
Share Issuance / Repurchase	25.14	24.27	0.01	33.38	124.33	40.25	Upgrade
Debt Issued / Paid	0	0	19.44	11.98	3.68	0	Upgrade
Other Financing Activities	-1.6	-1.58	-	-1.07	-5.61	-2.84	Upgrade
Financing Cash Flow	23.54	22.7	19.45	44.29	122.39	37.42	Upgrade
Exchange Rate Effect	0.14	0.11	-0.48	0.33	0.27	-0.09	Upgrade
Net Cash Flow	-27.8	-38.94	-59.07	27.87	-49.61	-15.06	Upgrade
Free Cash Flow	-51.48	-61.75	-78.04	-41.9	-48.05	-52.39	Upgrade
Free Cash Flow Margin	-547.03%	-711.24%	-7212.48%	-6640.73%	-4528.75%	-2358.62%	Upgrade
Free Cash Flow Per Share	-2.09	-3.96	-9.06	-4.93	-6.60	-13.16	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).